These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9215287)

  • 1. Augmented hepatic and skeletal thyromimetic effects of tiratricol in comparison with levothyroxine.
    Sherman SI; Ringel MD; Smith MJ; Kopelen HA; Zoghbi WA; Ladenson PW
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2153-8. PubMed ID: 9215287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-specific effects of tiratricol: a thyroid hormone analog with hepatic, not pituitary, superagonist effects.
    Sherman SI; Ladenson PW
    J Clin Endocrinol Metab; 1992 Sep; 75(3):901-5. PubMed ID: 1517383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the metabolic and endocrine effects of 3,5,3'-triiodothyroacetic acid and thyroxine.
    Bracco D; Morin O; Schutz Y; Liang H; Jéquier E; Burger AG
    J Clin Endocrinol Metab; 1993 Jul; 77(1):221-8. PubMed ID: 8325946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH.
    Gam AN; Jensen GF; Hasselstrøm K; Olsen M; Nielsen KS
    J Endocrinol Invest; 1991 Jun; 14(6):451-5. PubMed ID: 1774441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
    Konno N; Morikawa K
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.
    Bartalena L; Martino E; Pacchiarotti A; Grasso L; Aghini-Lombardi F; Buratti L; Bambini G; Breccia M; Pinchera A
    J Clin Endocrinol Metab; 1987 Apr; 64(4):849-55. PubMed ID: 3818906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study.
    Ladenson PW; McCarren M; Morkin E; Edson RG; Shih MC; Warren SR; Barnhill JG; Churby L; Thai H; O'Brien T; Anand I; Warner A; Hattler B; Dunlap M; Erikson J; Goldman S
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1349-54. PubMed ID: 20080837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
    Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-thyroxine treatment of preterm newborns: clinical and endocrine effects.
    Vanhole C; Aerssens P; Naulaers G; Casneuf A; Devlieger H; Van den Berghe G; de Zegher F
    Pediatr Res; 1997 Jul; 42(1):87-92. PubMed ID: 9212042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.
    Marcocci C; Golia F; Bruno-Bossio G; Vignali E; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):818-23. PubMed ID: 8157704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
    Marcocci C; Golia F; Vignali E; Pinchera A
    J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic blood markers reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism.
    Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B
    Acta Med Hung; 1991; 48(1-2):33-43. PubMed ID: 1813856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic markers in blood reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism.
    Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B
    Exp Clin Endocrinol; 1992; 99(3):129-33. PubMed ID: 1526260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
    Peterson ME; Melián C; Nichols R
    J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
    Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy.
    Saravanan P; Siddique H; Simmons DJ; Greenwood R; Dayan CM
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):261-7. PubMed ID: 17479444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid function from birth to adolescence in Prader-Willi syndrome.
    Sharkia M; Michaud S; Berthier MT; Giguère Y; Stewart L; Deladoëy J; Deal C; Van Vliet G; Chanoine JP
    J Pediatr; 2013 Sep; 163(3):800-5. PubMed ID: 23623517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism.
    Maeda M; Kuzuya N; Masuyama Y; Imai Y; Ikeda H
    J Clin Endocrinol Metab; 1976 Jul; 43(1):10-7. PubMed ID: 947930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.